A gold-standard diagnostic tool that combines professional-grade data depth with a remarkably intuitive 'Smart Guide' setup for patients.

Philips Alice NightOne Review: A Clinically Proven Staple for Professional-Grade Home Testing

Published Mar 24, 2026
|
Reviewed by Dr. Monica Garcia, PhD, MD
|
Testing 30 days
|
Evidence Strong Clinical Evidence
PEER REVIEWED

The Philips Alice NightOne remains a premier choice for clinical sleep apnea diagnosis at home, widely utilized by labs for its reliability and comprehensive 7-channel monitoring. It records pressure flow, snoring, respiratory effort (via RIP belts), SpO2, plethysmography, pulse rate, and body position. A standout clinical feature is the 'Auto-on' technology, which initiates recording immediately upon buckling the effort belt, effectively reducing common user errors that lead to failed studies. In clinical trials, the device demonstrated diagnostic agreement with simultaneously recorded in-lab PSG in 96.4% of cases, proving its efficacy as a hospital-grade surrogate. While the hardware was strategically discontinued by Philips in the U.S. in early 2024, it continues to be a 'workhorse' in circulation across European and established North American clinics through 2026 due to its robust construction and high-fidelity signal correlation.

Recommended Strong Clinical Evidence FDA 510(k) Cleared
Philips Alice NightOne Home Sleep Test - Medical Device

Philips Alice NightOne Home Sleep Test

Philips

$295.00
90 /100

Our Score

Clinical Performance Metrics

Quantitative assessment based on clinical testing protocols

Diagnostic Accuracy

Maintains an exceptionally high correlation (r=0.97) with PSG-derived AHI, making it reliable for moderate-to-severe OSA diagnosis.

96/100

Ease of Use

The illuminated Smart Guide Setup walks patients through sensor placement step-by-step, turning indicators from yellow to green upon signal acquisition.

92/100

Wearing Comfort

Includes a nasal cannula and chest belt; while more invasive than a patch, the RIP belt buckle design is more ergonomic than traditional belts.

85/100

Value for Money

Priced around $279, it provides medical-grade multi-channel data comparable to far more expensive lab studies.

88/100

Quick Take

Key findings from our clinical evaluation

+
Strengths

  • Auto-on feature starts recording as soon as the effort belt is clicked into place.
  • Smart Guide Setup with color-coded signal indicators ensures proper sensor placement.
  • Good Study Indicator provides immediate feedback on data quality in 25% increments.
  • Integrated Bluetooth connects to Philips PAP devices for therapy tracking.
  • High-fidelity Respiratory Inductance Plethysmography (RIP) for direct effort measurement.

Limitations

  • Philips officially discontinued the device in the U.S. in early 2024, affecting new availability.
  • Nasal cannula can cause minor discomfort or become dislodged for active sleepers.
  • Requires clinical software (Sleepware G3) on a PC for detailed data download and analysis.

Real-World Usage

Practical considerations for daily operation

Daily Routine Impact

Requires about 10 minutes of setup before bed. The device is compact (roughly the size of a smartphone) and worn over pajamas, causing minimal interference with normal movement.

Learning Curve

Master in an hour

Maintenance

Reusable device; requires periodic cleaning with mild soapy water or 70% alcohol and replacement of 2x AA batteries.

Portability

High; comes with a hard-shell carrying case that protects the sensor module and accessories while traveling.

Manual Use

Patients primarily interact with the front User Button to check signal status and end the study; all other recording is automated.

Cost & Coverage Analysis

Financial considerations and HSA / FSA eligibility

Pricing Breakdown

Device Price $295.00
Disposable Nasal Cannulas (Single-use pressure-sensing cannula.)
$5.00 / per test
HSA / FSA Eligibility Usually Eligible

HSA/FSA Guidance

Standard Type III HSAT typically covered under CPT 95806; providers can still bill for studies using existing Alice NightOne stock.

Cost Comparison

Cheaper than one-time costs for some higher-end Type II systems, making it highly cost-effective for labs.

Patient Suitability

Clinical indications and contraindications

Indicated For

  • Patients seeking a medically rigorous study with direct effort and flow channels.
  • Labs looking for a durable, reusable device with low patient-setup failure rates.
  • Clinicians already utilizing the Philips Sleepware G3 ecosystem for data management.

Contraindications

  • Users who want a fully disposable, no-return testing option.
  • Individuals with extreme facial sensitivity to nasal cannulas.

Age Considerations

Indicated for use in adult patients only.

Clinical Efficacy Assessment

Evidence-based evaluation of clinical performance

AHI Detection Accuracy

Ability to accurately count apnea and hypopnea events per hour.

Reliably distinguishes between obstructive and central events using a combination of flow and RIP effort data.

Sleep Stage Identification

Accuracy in identifying sleep architecture (REM/NREM).

Uses respiratory-derived sleep proxies via Sleepware G3 software; effective but lacks true EEG for staging precision.

Respiratory Event Detection

Sensitivity in identifying specific respiratory obstructions and effort.

Utilizes AASM-recommended sensor types, ensuring high sensitivity to snoring and oxygen desaturation events.

In-Lab PSG Correlation

Statistical alignment with gold-standard hospital studies.

Shown to have agreement in diagnostic categorization for 97% of patients when compared to attended PSG.

Comparative Performance

Ranked #10 of 24 clinically evaluated home sleep tests devices

1
Withings Sleep Analyzer

Withings Sleep Analyzer

Withings

Top Rated
2
Sunrise Home Sleep Test

Sunrise Home Sleep Test

Sunrise SA

3
NightOwl Home Sleep Apnea Test

NightOwl Home Sleep Apnea Test

ResMed

10
Philips Alice NightOne Home Sleep Test

Philips Alice NightOne Home Sleep Test

Philips

You're viewing this
90 /100

Clinical Context

Our #1-ranked home sleep tests device demonstrated superior performance across key clinical metrics. Compare detailed specifications to make an evidence-based selection.

Clinical Recommendation

Final assessment and prescribing guidance

The Alice NightOne is a masterpiece of clinical diagnostic design. Despite its 2024 discontinuation for new sales, its legacy as a top-performing Type III recorder remains unchallenged in early 2026.

Recommend If

You can access one through a local sleep clinic and want a high-fidelity study with integrated error-reduction features.

Avoid If

You require a newer device with direct-to-consumer app support for real-time personal data viewing.

Clinical Summary

90 /100

Composite Score

Recommended

Recommendation

$295

Price Point

Evidence: Strong
Tested: 30 days

Where to Buy

Verified purchase options and current availability

Sleep Foundation

Price: $295.00
3-5 business days

Includes sleep specialist consultation and board-certified results.

Shop Now

Important Information

  • • Prices and availability subject to change
  • • Some devices may require a prescription
  • • HSA / FSA eligibility: Usually Eligible
  • • Purchase from authorized retailers for warranty protection
Visit Manufacturer Website

Alternative Devices

Alice NightOne offers more comprehensive signal indicators and setup guidance than the ApneaLink Air, though ApneaLink Air remains actively sold in the U.S..

Testing Methodology

Randomized controlled trial comparing Alice NightOne (PDX) diagnostic accuracy against simultaneously recorded hospital-based PSG in adult patients with suspected OSA.

Medical Review: Sleep specialists value the Alice NightOne for its 'Good Study Indicator' (GSI), which allows patients to verify that they have captured at least 25% increments of valid data before returning the device, significantly reducing 'junk' studies.

Medical Disclaimer

This review is for informational purposes only and does not constitute medical advice. Individual results may vary. Always consult with healthcare professionals before making medical device decisions. Clinical recommendations should be individualized based on patient-specific factors.